Bioasis Technologies Inc.
BIOAF
$0.00
$0.00-66.67%
OTC PK
| 11/30/2022 | 08/31/2022 | ||||
|---|---|---|---|---|---|
| Revenue | 18.31% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 18.31% | -- | |||
| Cost of Revenue | -14.11% | -- | |||
| Gross Profit | 45.22% | -- | |||
| SG&A Expenses | -22.56% | 70.14% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -20.52% | 59.73% | |||
| Operating Income | 25.71% | -40.86% | |||
| Income Before Tax | 13.53% | -360.82% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 13.53% | -360.82% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 13.53% | -360.82% | |||
| EBIT | 25.71% | -40.86% | |||
| EBITDA | 26.86% | -38.95% | |||
| EPS Basic | 13.89% | -332.00% | |||
| Normalized Basic EPS | 14.71% | -325.00% | |||
| EPS Diluted | 13.89% | -332.00% | |||
| Normalized Diluted EPS | 14.71% | -325.00% | |||
| Average Basic Shares Outstanding | 0.00% | 7.27% | |||
| Average Diluted Shares Outstanding | 0.00% | 7.27% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||